Co-Infection
Zeile 3: | Zeile 3: | ||
{{tp|p=32297939|t=ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise |pdf=|usr=}} | {{tp|p=32297939|t=ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise |pdf=|usr=}} | ||
{{tp|p=32293646|t=ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens |pdf=|usr=}} | {{tp|p=32293646|t=ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens |pdf=|usr=}} | ||
− | + | {{tp|p=32475878|t=2020. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.|pdf=|usr=007}} | |
{{tp|p=32192233|t=2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus |pdf=|usr=}} | {{tp|p=32192233|t=2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus |pdf=|usr=}} | ||
{{tp|p=32170625|t=ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients |pdf=|usr=}} | {{tp|p=32170625|t=ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients |pdf=|usr=}} | ||
{{tp|p=32305630|t=ä. A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens |pdf=|usr=}} | {{tp|p=32305630|t=ä. A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens |pdf=|usr=}} | ||
− | + | {{tp|p=32453917|t=2020. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?|pdf=|usr=007}} | |
{{tp|p=32173883|t=ä. COVID?19 and mycoplasma pneumoniae coinfection |pdf=|usr=}} | {{tp|p=32173883|t=ä. COVID?19 and mycoplasma pneumoniae coinfection |pdf=|usr=}} | ||
{{tp|p=32314699|t=2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic |pdf=|usr=}} | {{tp|p=32314699|t=2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic |pdf=|usr=}} | ||
Zeile 13: | Zeile 13: | ||
{{ttp|p=32374823|t=2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |pdf=|usr=}} | {{ttp|p=32374823|t=2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |pdf=|usr=}} | ||
{{tp|p=32379863|t=ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization |pdf=|usr=}} | {{tp|p=32379863|t=ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization |pdf=|usr=}} | ||
− | + | {{tp|p=32441243|t=2020. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.|pdf=|usr=007}} | |
{{tp|p=32301747|t=2020. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children |pdf=|usr=}} | {{tp|p=32301747|t=2020. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children |pdf=|usr=}} | ||
{{tp|p=32292053|t=2020. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report |pdf=|usr=}} | {{tp|p=32292053|t=2020. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report |pdf=|usr=}} | ||
{{tp|p=32362302|t=ä. To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area |pdf=|usr=}} | {{tp|p=32362302|t=ä. To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area |pdf=|usr=}} | ||
− | + | {{tp|p=32427361|t=2020. Four cases: Human immunodeficiency virus and novel coronavirus 2019 Co-infection in patients from Long Island, New York.|pdf=|usr=007}} | |
{{tp|p=32339350|t=2020. COVID-19 associated pulmonary aspergillosis |pdf=|usr=}} | {{tp|p=32339350|t=2020. COVID-19 associated pulmonary aspergillosis |pdf=|usr=}} | ||
{{tp|p=32379193|t=2020. A CASE OF CHILDHOOD COVID-19 INFECTION WITH PLEURAL EFFUSION COMPLICATED BY POSSIBLE SECONDARY MYCOPLASMA PNEUMONIAE INFECTION |pdf=|usr=}} | {{tp|p=32379193|t=2020. A CASE OF CHILDHOOD COVID-19 INFECTION WITH PLEURAL EFFUSION COMPLICATED BY POSSIBLE SECONDARY MYCOPLASMA PNEUMONIAE INFECTION |pdf=|usr=}} | ||
Zeile 23: | Zeile 23: | ||
{{tp|p=32376725|t=2020. Co-infection and Other Clinical Characteristics of COVID-19 in Children |pdf=|usr=}} | {{tp|p=32376725|t=2020. Co-infection and Other Clinical Characteristics of COVID-19 in Children |pdf=|usr=}} | ||
{{tp|p=32238260|t=2020. Coinfeccion entre dengue y COVID-19: Necesidad de abordaje en zonas endemicas |pdf=|usr=}} | {{tp|p=32238260|t=2020. Coinfeccion entre dengue y COVID-19: Necesidad de abordaje en zonas endemicas |pdf=|usr=}} | ||
− | + | {{tp|p=32392591|t=2020. SARS CoV-2 und Influenza A-Ko-Infektion bei einem padiatrischen Patienten in Deutschland.|pdf=|usr=007}} | |
{{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}} | {{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}} | ||
{{tp|p=32423586|t=2020. SARS-CoV-2 and influenza virus co-infection |pdf=|usr=}} | {{tp|p=32423586|t=2020. SARS-CoV-2 and influenza virus co-infection |pdf=|usr=}} | ||
{{tp|p=32402687|t=ä. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography |pdf=|usr=}} | {{tp|p=32402687|t=ä. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography |pdf=|usr=}} | ||
− | + | {{tp|p=32503617|t=2020. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.|pdf=|usr=007}} | |
{{ttp|p=32265235|t=2020. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case |pdf=|usr=}} | {{ttp|p=32265235|t=2020. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case |pdf=|usr=}} | ||
{{tp|p=32196707|t=ä. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China |pdf=|usr=}} | {{tp|p=32196707|t=ä. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China |pdf=|usr=}} | ||
Zeile 33: | Zeile 33: | ||
{{tp|p=32320082|t=2020. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia |pdf=|usr=}} | {{tp|p=32320082|t=2020. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia |pdf=|usr=}} | ||
{{tp|p=32293743|t=2020. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated |pdf=|usr=}} | {{tp|p=32293743|t=2020. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated |pdf=|usr=}} | ||
+ | {{tp|p=32470211|t=2020. Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?|pdf=|usr=007}} | ||
+ | {{tp|p=32441773|t=2020. COVID-19 in a patient with HIV infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32449972|t=2020. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.|pdf=|usr=007}} | ||
+ | {{tp|p=32449792|t=2020. Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.|pdf=|usr=007}} | ||
+ | {{tp|p=32462695|t=2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32437000|t=2020. HIV and SARS-CoV-2 coinfection: A case report from Uganda.|pdf=|usr=007}} | ||
+ | {{tp|p=32462663|t=2020. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.|pdf=|usr=007}} | ||
+ | {{tp|p=32505530|t=2020. Co-infection with an atypical pathogen of COVID-19 in a young.|pdf=|usr=007}} | ||
+ | {{tp|p=32448041|t=2020. Covid-19 induced superimposed bacterial infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32393593|t=2020. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32497283|t=2020. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32492188|t=2020. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.|pdf=|usr=007}} | ||
+ | {{tp|p=32483000|t=2020. COVID-19 pneumonia in patients with HIV - A Case Series.|pdf=|usr=007}} | ||
+ | {{tp|p=32449248|t=2020. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32404716|t=2020. A case of HIV and SARS-CoV-2 co-infection in Singapore.|pdf=|usr=007}} | ||
+ | {{tp|p=32238235|t=2020. Da Tuberculose ao COVID-19: Legitimidade Juridico-Constitucional do Isolamento/Tratamento Compulsivo por Doencas Contagiosas em Portugal.|pdf=|usr=007}} | ||
+ | |||
+ | {{tp|p=32500854|t=2020. Primary Respiratory Bacterial Coinfections in Patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32396381|t=2020. COVID-19 Associated Pulmonary Aspergillosis.|pdf=|usr=007}} | ||
+ | {{tp|p=32501851|t=2020. SARS-CoV-2 infection in a highly experienced person living with HIV.|pdf=|usr=007}} | ||
+ | {{tp|p=32501850|t=2020. Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.|pdf=|usr=007}} | ||
+ | {{tp|p=32469614|t=2020. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.|pdf=|usr=007}} | ||
+ | {{tp|p=32407127|t=2020. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?|pdf=|usr=007}} | ||
+ | |||
+ | |||
+ | {{tp|p=32412848|t=2020. A Case of COVID-19 and Pneumocystis jirovecii Co-infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32459833|t=2020. Hospitalized patients with COVID-19 and HIV: a case series.|pdf=|usr=007}} | ||
+ | |||
+ | {{tp|p=32472138|t=2020. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.|pdf=|usr=007}} |
Version vom 28. Juni 2020, 20:25 Uhr
32307254 ä. Invasive fungal diseases during COVID-19: We should be prepared
32297939 ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise
32293646 ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
32475878 2020. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.
32192233 2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus
32170625 ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients
32305630 ä. A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens
32453917 2020. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?
32173883 ä. COVID?19 and mycoplasma pneumoniae coinfection
32314699 2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic
32271596 2020. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran
32374823 2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |
32379863 ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization
32441243 2020. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.
32301747 2020. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children
32292053 2020. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report
32362302 ä. To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area
32427361 2020. Four cases: Human immunodeficiency virus and novel coronavirus 2019 Co-infection in patients from Long Island, New York.
32339350 2020. COVID-19 associated pulmonary aspergillosis
32379193 2020. A CASE OF CHILDHOOD COVID-19 INFECTION WITH PLEURAL EFFUSION COMPLICATED BY POSSIBLE SECONDARY MYCOPLASMA PNEUMONIAE INFECTION
32287051 2020. Coinfection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)
32376725 2020. Co-infection and Other Clinical Characteristics of COVID-19 in Children
32238260 2020. Coinfeccion entre dengue y COVID-19: Necesidad de abordaje en zonas endemicas
32392591 2020. SARS CoV-2 und Influenza A-Ko-Infektion bei einem padiatrischen Patienten in Deutschland.
C7195315 2020. Co-infections: potentially lethal and unexplored in COVID-19
32423586 2020. SARS-CoV-2 and influenza virus co-infection
32402687 ä. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography
32503617 2020. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.
32265235 2020. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case |
32196707 ä. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
32352574 2020. Co-infection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?
32320082 2020. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia
32293743 2020. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated
32470211 2020. Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?
32441773 2020. COVID-19 in a patient with HIV infection.
32449972 2020. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.
32449792 2020. Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.
32462695 2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.
32437000 2020. HIV and SARS-CoV-2 coinfection: A case report from Uganda.
32462663 2020. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.
32505530 2020. Co-infection with an atypical pathogen of COVID-19 in a young.
32448041 2020. Covid-19 induced superimposed bacterial infection.
32393593 2020. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19.
32497283 2020. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.
32492188 2020. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
32483000 2020. COVID-19 pneumonia in patients with HIV - A Case Series.
32449248 2020. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.
32404716 2020. A case of HIV and SARS-CoV-2 co-infection in Singapore.
32238235 2020. Da Tuberculose ao COVID-19: Legitimidade Juridico-Constitucional do Isolamento/Tratamento Compulsivo por Doencas Contagiosas em Portugal.
32500854 2020. Primary Respiratory Bacterial Coinfections in Patients with COVID-19.
32396381 2020. COVID-19 Associated Pulmonary Aspergillosis.
32501851 2020. SARS-CoV-2 infection in a highly experienced person living with HIV.
32501850 2020. Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.
32469614 2020. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.
32407127 2020. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?
32412848 2020. A Case of COVID-19 and Pneumocystis jirovecii Co-infection.
32459833 2020. Hospitalized patients with COVID-19 and HIV: a case series.
32472138 2020. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.